Genovis AB (publ.) (STO:GENO)
Sweden
· Delayed Price · Currency is SEK 29.10
+1.25 (4.49%)
At close: Feb 17, 2025
Genovis AB (publ.) Revenue
In the year 2024, Genovis AB (publ.) had annual revenue of 146.00M SEK, down -8.22%. Genovis AB (publ.) had revenue of 28.02M in the quarter ending December 31, 2024, a decrease of -0.44%.
Revenue
146.00M
Revenue Growth
-8.22%
P/S Ratio
12.69
Revenue / Employee
4.56M
Employees
32
Market Cap
1.85B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 146.00M | -13.07M | -8.22% |
| Dec 31, 2023 | 159.07M | 55.51M | 53.60% |
| Dec 31, 2022 | 103.56M | 9.89M | 10.55% |
| Dec 31, 2021 | 93.68M | 32.65M | 53.49% |
| Dec 31, 2020 | 61.03M | 480.58K | 0.79% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.03B |
| Getinge AB | 34.76B |
| Sectra AB | 3.14B |
| Camurus AB | 1.87B |
| Medicover AB | 23.97B |
| Vitrolife AB | 3.61B |
| Elekta AB | 17.88B |
| Vimian Group AB | 4.29B |
Genovis AB (publ.) News
- 3 months ago - Genovis AB (OSTO:GENO) Q3 2024 Earnings Report Preview: What to Expect - GuruFocus